Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 1, no: 28 |
NetGPI | no | yes: 0, no: 29 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 14 |
GO:0110165 | cellular anatomical entity | 1 | 16 |
GO:0005737 | cytoplasm | 2 | 2 |
GO:0005739 | mitochondrion | 5 | 1 |
GO:0043226 | organelle | 2 | 1 |
GO:0043227 | membrane-bounded organelle | 3 | 1 |
GO:0043229 | intracellular organelle | 3 | 1 |
GO:0043231 | intracellular membrane-bounded organelle | 4 | 1 |
Related structures:
AlphaFold database: E9AX26
Term | Name | Level | Count |
---|---|---|---|
GO:0006082 | organic acid metabolic process | 3 | 1 |
GO:0006629 | lipid metabolic process | 3 | 1 |
GO:0006631 | fatty acid metabolic process | 4 | 1 |
GO:0006633 | fatty acid biosynthetic process | 5 | 1 |
GO:0008152 | metabolic process | 1 | 1 |
GO:0008610 | lipid biosynthetic process | 4 | 1 |
GO:0009058 | biosynthetic process | 2 | 1 |
GO:0009987 | cellular process | 1 | 1 |
GO:0016053 | organic acid biosynthetic process | 4 | 1 |
GO:0019752 | carboxylic acid metabolic process | 5 | 1 |
GO:0030497 | fatty acid elongation | 6 | 1 |
GO:0032787 | monocarboxylic acid metabolic process | 6 | 1 |
GO:0043436 | oxoacid metabolic process | 4 | 1 |
GO:0044237 | cellular metabolic process | 2 | 1 |
GO:0044238 | primary metabolic process | 2 | 1 |
GO:0044249 | cellular biosynthetic process | 3 | 1 |
GO:0044255 | cellular lipid metabolic process | 3 | 1 |
GO:0044281 | small molecule metabolic process | 2 | 1 |
GO:0044283 | small molecule biosynthetic process | 3 | 1 |
GO:0046394 | carboxylic acid biosynthetic process | 5 | 1 |
GO:0071704 | organic substance metabolic process | 2 | 1 |
GO:0072330 | monocarboxylic acid biosynthetic process | 6 | 1 |
GO:1901576 | organic substance biosynthetic process | 3 | 1 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 3 |
GO:0004312 | fatty acid synthase activity | 5 | 3 |
GO:0004316 | 3-oxoacyl-[acyl-carrier-protein] reductase (NADPH) activity | 5 | 3 |
GO:0016491 | oxidoreductase activity | 2 | 3 |
GO:0016614 | oxidoreductase activity, acting on CH-OH group of donors | 3 | 3 |
GO:0016616 | oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor | 4 | 3 |
GO:0016740 | transferase activity | 2 | 3 |
GO:0016746 | acyltransferase activity | 3 | 3 |
GO:0016747 | acyltransferase activity, transferring groups other than amino-acyl groups | 4 | 3 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_MEL_PAP_1 | 183 | 189 | PF00089 | 0.259 |
CLV_NRD_NRD_1 | 301 | 303 | PF00675 | 0.587 |
CLV_NRD_NRD_1 | 308 | 310 | PF00675 | 0.536 |
CLV_NRD_NRD_1 | 75 | 77 | PF00675 | 0.366 |
CLV_PCSK_KEX2_1 | 159 | 161 | PF00082 | 0.266 |
CLV_PCSK_KEX2_1 | 308 | 310 | PF00082 | 0.547 |
CLV_PCSK_KEX2_1 | 75 | 77 | PF00082 | 0.393 |
CLV_PCSK_PC1ET2_1 | 159 | 161 | PF00082 | 0.284 |
CLV_PCSK_PC7_1 | 155 | 161 | PF00082 | 0.258 |
CLV_PCSK_SKI1_1 | 181 | 185 | PF00082 | 0.215 |
CLV_PCSK_SKI1_1 | 279 | 283 | PF00082 | 0.523 |
CLV_PCSK_SKI1_1 | 81 | 85 | PF00082 | 0.356 |
DEG_Nend_Nbox_1 | 1 | 3 | PF02207 | 0.656 |
DOC_MAPK_HePTP_8 | 183 | 195 | PF00069 | 0.392 |
DOC_MAPK_MEF2A_6 | 186 | 195 | PF00069 | 0.435 |
DOC_PP4_FxxP_1 | 197 | 200 | PF00568 | 0.485 |
DOC_USP7_MATH_1 | 133 | 137 | PF00917 | 0.480 |
DOC_USP7_MATH_1 | 161 | 165 | PF00917 | 0.491 |
DOC_USP7_MATH_1 | 273 | 277 | PF00917 | 0.486 |
DOC_USP7_MATH_1 | 280 | 284 | PF00917 | 0.607 |
DOC_USP7_MATH_1 | 319 | 323 | PF00917 | 0.769 |
DOC_USP7_MATH_1 | 334 | 338 | PF00917 | 0.589 |
DOC_USP7_UBL2_3 | 434 | 438 | PF12436 | 0.361 |
DOC_WW_Pin1_4 | 116 | 121 | PF00397 | 0.586 |
DOC_WW_Pin1_4 | 242 | 247 | PF00397 | 0.549 |
DOC_WW_Pin1_4 | 345 | 350 | PF00397 | 0.516 |
DOC_WW_Pin1_4 | 357 | 362 | PF00397 | 0.537 |
LIG_14-3-3_CanoR_1 | 18 | 22 | PF00244 | 0.606 |
LIG_14-3-3_CanoR_1 | 3 | 8 | PF00244 | 0.638 |
LIG_14-3-3_CanoR_1 | 341 | 349 | PF00244 | 0.480 |
LIG_BRCT_BRCA1_1 | 358 | 362 | PF00533 | 0.612 |
LIG_CSL_BTD_1 | 243 | 246 | PF09270 | 0.555 |
LIG_eIF4E_1 | 370 | 376 | PF01652 | 0.282 |
LIG_FHA_1 | 18 | 24 | PF00498 | 0.578 |
LIG_FHA_1 | 202 | 208 | PF00498 | 0.451 |
LIG_FHA_1 | 27 | 33 | PF00498 | 0.448 |
LIG_FHA_1 | 331 | 337 | PF00498 | 0.692 |
LIG_FHA_1 | 78 | 84 | PF00498 | 0.598 |
LIG_FHA_1 | 92 | 98 | PF00498 | 0.460 |
LIG_FHA_2 | 377 | 383 | PF00498 | 0.317 |
LIG_HCF-1_HBM_1 | 11 | 14 | PF13415 | 0.560 |
LIG_LIR_Apic_2 | 276 | 280 | PF02991 | 0.648 |
LIG_LIR_Gen_1 | 149 | 157 | PF02991 | 0.465 |
LIG_LIR_Gen_1 | 20 | 28 | PF02991 | 0.568 |
LIG_LIR_Gen_1 | 363 | 374 | PF02991 | 0.404 |
LIG_LIR_Nem_3 | 149 | 154 | PF02991 | 0.440 |
LIG_LIR_Nem_3 | 363 | 369 | PF02991 | 0.361 |
LIG_Pex14_2 | 362 | 366 | PF04695 | 0.442 |
LIG_PTB_Apo_2 | 395 | 402 | PF02174 | 0.289 |
LIG_PTB_Phospho_1 | 395 | 401 | PF10480 | 0.291 |
LIG_RPA_C_Fungi | 64 | 76 | PF08784 | 0.476 |
LIG_SH2_GRB2like | 402 | 405 | PF00017 | 0.331 |
LIG_SH2_PTP2 | 373 | 376 | PF00017 | 0.474 |
LIG_SH2_SRC | 371 | 374 | PF00017 | 0.225 |
LIG_SH2_SRC | 407 | 410 | PF00017 | 0.452 |
LIG_SH2_STAP1 | 312 | 316 | PF00017 | 0.671 |
LIG_SH2_STAT5 | 128 | 131 | PF00017 | 0.278 |
LIG_SH2_STAT5 | 157 | 160 | PF00017 | 0.358 |
LIG_SH2_STAT5 | 182 | 185 | PF00017 | 0.208 |
LIG_SH2_STAT5 | 201 | 204 | PF00017 | 0.358 |
LIG_SH2_STAT5 | 220 | 223 | PF00017 | 0.316 |
LIG_SH2_STAT5 | 237 | 240 | PF00017 | 0.382 |
LIG_SH2_STAT5 | 368 | 371 | PF00017 | 0.282 |
LIG_SH2_STAT5 | 373 | 376 | PF00017 | 0.259 |
LIG_SH2_STAT5 | 41 | 44 | PF00017 | 0.368 |
LIG_SH3_3 | 240 | 246 | PF00018 | 0.495 |
LIG_SH3_3 | 47 | 53 | PF00018 | 0.418 |
LIG_SUMO_SIM_anti_2 | 111 | 116 | PF11976 | 0.360 |
LIG_SUMO_SIM_par_1 | 333 | 339 | PF11976 | 0.364 |
LIG_TYR_ITIM | 369 | 374 | PF00017 | 0.340 |
MOD_CDK_SPK_2 | 242 | 247 | PF00069 | 0.445 |
MOD_CK1_1 | 283 | 289 | PF00069 | 0.550 |
MOD_CK1_1 | 307 | 313 | PF00069 | 0.622 |
MOD_CK1_1 | 322 | 328 | PF00069 | 0.694 |
MOD_CK2_1 | 3 | 9 | PF00069 | 0.543 |
MOD_CK2_1 | 322 | 328 | PF00069 | 0.473 |
MOD_CK2_1 | 376 | 382 | PF00069 | 0.384 |
MOD_Cter_Amidation | 300 | 303 | PF01082 | 0.482 |
MOD_Cter_Amidation | 73 | 76 | PF01082 | 0.506 |
MOD_GlcNHglycan | 135 | 138 | PF01048 | 0.341 |
MOD_GlcNHglycan | 238 | 241 | PF01048 | 0.499 |
MOD_GlcNHglycan | 26 | 29 | PF01048 | 0.583 |
MOD_GlcNHglycan | 309 | 312 | PF01048 | 0.650 |
MOD_GlcNHglycan | 324 | 327 | PF01048 | 0.599 |
MOD_GlcNHglycan | 362 | 365 | PF01048 | 0.400 |
MOD_GlcNHglycan | 94 | 97 | PF01048 | 0.316 |
MOD_GSK3_1 | 280 | 287 | PF00069 | 0.638 |
MOD_GSK3_1 | 330 | 337 | PF00069 | 0.460 |
MOD_GSK3_1 | 356 | 363 | PF00069 | 0.420 |
MOD_GSK3_1 | 41 | 48 | PF00069 | 0.415 |
MOD_GSK3_1 | 77 | 84 | PF00069 | 0.507 |
MOD_GSK3_1 | 88 | 95 | PF00069 | 0.284 |
MOD_N-GLC_2 | 389 | 391 | PF02516 | 0.307 |
MOD_N-GLC_2 | 77 | 79 | PF02516 | 0.325 |
MOD_NEK2_1 | 24 | 29 | PF00069 | 0.487 |
MOD_NEK2_1 | 356 | 361 | PF00069 | 0.413 |
MOD_NEK2_1 | 362 | 367 | PF00069 | 0.295 |
MOD_NEK2_1 | 412 | 417 | PF00069 | 0.518 |
MOD_NEK2_1 | 60 | 65 | PF00069 | 0.325 |
MOD_PIKK_1 | 319 | 325 | PF00454 | 0.693 |
MOD_PIKK_1 | 381 | 387 | PF00454 | 0.298 |
MOD_PKA_2 | 161 | 167 | PF00069 | 0.360 |
MOD_PKA_2 | 17 | 23 | PF00069 | 0.500 |
MOD_PKA_2 | 24 | 30 | PF00069 | 0.427 |
MOD_PKA_2 | 287 | 293 | PF00069 | 0.671 |
MOD_PKA_2 | 296 | 302 | PF00069 | 0.727 |
MOD_PKA_2 | 307 | 313 | PF00069 | 0.666 |
MOD_PKA_2 | 340 | 346 | PF00069 | 0.355 |
MOD_PKA_2 | 77 | 83 | PF00069 | 0.453 |
MOD_Plk_1 | 110 | 116 | PF00069 | 0.305 |
MOD_Plk_4 | 233 | 239 | PF00069 | 0.438 |
MOD_Plk_4 | 3 | 9 | PF00069 | 0.534 |
MOD_Plk_4 | 362 | 368 | PF00069 | 0.386 |
MOD_Plk_4 | 383 | 389 | PF00069 | 0.306 |
MOD_Plk_4 | 60 | 66 | PF00069 | 0.303 |
MOD_ProDKin_1 | 116 | 122 | PF00069 | 0.480 |
MOD_ProDKin_1 | 242 | 248 | PF00069 | 0.427 |
MOD_ProDKin_1 | 345 | 351 | PF00069 | 0.390 |
MOD_ProDKin_1 | 357 | 363 | PF00069 | 0.409 |
MOD_SUMO_for_1 | 437 | 440 | PF00179 | 0.482 |
TRG_ENDOCYTIC_2 | 371 | 374 | PF00928 | 0.365 |
TRG_ER_diArg_1 | 75 | 78 | PF00400 | 0.376 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P2S7 | Leptomonas seymouri | 33% | 86% |
A0A0N1HZ81 | Leptomonas seymouri | 70% | 79% |
A0A0S4IWT0 | Bodo saltans | 33% | 94% |
A0A0S4IZG2 | Bodo saltans | 36% | 97% |
A0A0S4J1I6 | Bodo saltans | 44% | 100% |
A0A1X0NVT8 | Trypanosomatidae | 34% | 88% |
A0A1X0NVV6 | Trypanosomatidae | 50% | 86% |
A0A3Q8ID46 | Leishmania donovani | 35% | 87% |
A0A3R7K071 | Trypanosoma rangeli | 53% | 91% |
A0A3S5H7D5 | Leishmania donovani | 95% | 100% |
A0A3S7X986 | Leishmania donovani | 24% | 91% |
A0A422N2B6 | Trypanosoma rangeli | 33% | 92% |
A4HDP2 | Leishmania braziliensis | 87% | 100% |
A4HDP3 | Leishmania braziliensis | 33% | 97% |
A4HMN7 | Leishmania braziliensis | 27% | 100% |
C9ZWC0 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 31% | 93% |
C9ZWC1 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 51% | 88% |
C9ZZF1 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 26% | 100% |
E9AF41 | Leishmania major | 22% | 100% |
E9AH88 | Leishmania infantum | 95% | 88% |
E9AH89 | Leishmania infantum | 34% | 87% |
E9AHV8 | Leishmania infantum | 24% | 91% |
E9AX27 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 34% | 87% |
E9B696 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 24% | 91% |
Q4QAE9 | Leishmania major | 33% | 100% |
Q4QAF0 | Leishmania major | 94% | 100% |
V5BAF4 | Trypanosoma cruzi | 33% | 92% |
V5BNY6 | Trypanosoma cruzi | 28% | 100% |